← Open Payments lookup

LETICIA KHOSAMA: Open Payments

NPI 1063768737 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,080 in 31 payments from 16 companies in 2025. Trend: 2023 $3,110 · 2024 $1,540 · 2025 $1,080

Food & beverage: $705Long term medical supply or device loan: $199Education: $176
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation5$280
Janssen Biotech, Inc.2$101
E.R. Squibb & Sons, L.L.C.2$100
Incyte Corporation4$97
Daiichi Sankyo Inc.1$96
Lilly USA, LLC3$75
Stemline Therapeutics Inc.3$67
Merck Sharp & Dohme LLC2$62
Bayer Healthcare Pharmaceuticals Inc.2$45
AstraZeneca Pharmaceuticals LP1$31

Products named: KISQALI, ENHERTU, ERLEADA, VERZENIO, MONJUVI, Orserdu, KEYTRUDA, Nubeqa.

Industry payments across TX — which companies pay providers there.